South Korean court halts KRX delisting decision against KM Pharmaceutical pending main lawsuit

Bitget2026/10/02 09:36

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Seoul Southern District Court ordered a suspension of the Korea Exchange’s Sept. 14 delisting decision on KMPharmaceutical shares.
The injunction remains in effect until a final ruling in the main lawsuit, blocking the exchange from starting the liquidation trading process.
The court decision was confirmed on Oct. 2, 2026; the outcome could change depending on the main case or appeal steps.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. KMPharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261002901024), on October 02, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

South Korean court halts KRX delisting decision against KM Pharmaceutical pending main lawsuit

You may also like

Crypto prices